Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Clinical Trial to Assess Tolerability and Availability of a Multi-target Dietary Supplement in an Aging Population
Authors not listed
Douglas Boreham · 2021
Abstract
This study is being performed to determine if a multi-ingredient dietary supplement is safe and easy to take by healthy older adults. Participants will be required to take one of three different doses of the dietary supplement for 90 consecutive days and complete wellness surveys and a daily log while taking the supplement. Participants will also provide blood samples at the start of the study, after 30 days, and at the end of the study which will help determine how participants respond to the supplement.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-30 MST
Cite this
APA
Anonymous. (2021). Clinical Trial to Assess Tolerability and Availability of a Multi-target Dietary Supplement in an Aging Population. <em>Douglas Boreham</em>. https://clinicaltrials.gov/study/NCT04641663
Vancouver
Anonymous. Clinical Trial to Assess Tolerability and Availability of a Multi-target Dietary Supplement in an Aging Population. Douglas Boreham. 2021.
BibTeX
@misc{anon2021Clinic,
title = {Clinical Trial to Assess Tolerability and Availability of a Multi-target Dietary Supplement in an Aging Population},
author = {Anonymous},
journal = {Douglas Boreham},
year = {2021},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Augusta University 2026
Open access · US-GOV
Dietary Supplementation With EVOO Phenolics Prevents MCI Progression to Alzheimer's Disease
Johns Hopkins University 2012
Open access · US-GOV
Cognitive Effects of Transcranial Direct Current Stimulation in Older Adults
Helse Stavanger HF 2023
Open access · US-GOV
Tolerability and Effects of a New Omega-3 Fatty Acid-based Supplement on Clinical and Biological Markers of Healthy Ageing
Atria Research and Global Health Institute (ARGHI) 2025
Open access · US-GOV
Iterative Design Trial to Assess Dietary Supplements and Other Aging-targeted Therapies
Animuscure Inc. 2025
Open access · US-GOV
A Multicenter, Randomized, Double-Blind, Placebo-controlled, Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of AMC6156 in Patients With Sarcopenia
University of Primorska 2026
Open access · US-GOV